NEW YORK (GenomeWeb News) – Following Illumina's purchase of Advanced Liquid Logic in July, GenMark has liquidated its preferred stock investment in ALL but retained its license to the firm's digital microfluidics technology, GenMark said in its Form 10-Q filed with the US Securities and Exchange Commission this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: factors affecting the success of whole-genome sequencing for routine clinical diagnosis, and more.

A large meta-analysis from an international team reports that nature and nurture have about an equal overall influence on human traits.

The Lasker Foundation's Claire Pomeroy laments the state of NIH funding at Forbes.

Social media is changing how scientists discuss research, as tweets from University of Chicago's Yoav Gilad about a Mouse ENCODE paper have shown, Nature reports.